{
  "id": 3256772,
  "title": "Bristol Myers ends deal with Cellares, cell therapy manufacturer to reorg",
  "url": "https://urgent.news/2026/08/25/bristol-myers-ends-deal-with-cellares-cell-therapy-manufacturer-to",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-25T12:00:45.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/bristol-myers-ends-deal-with-cellares-cell-therapy-manufacturer-to-reorg/"
  },
  "original_language": "en",
  "account": null,
  "summary": "After a “comprehensive evaluation,” Bristol Myers Squibb has pulled out of its partnership with Cellares and the cell therapy manufacturer will restructure as a result. Bristol Myers determined that the manufacturer’s Cell Shuttle system “could ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "BioPharma Dive",
        "title": "Cellares, a cell therapy manufacturing specialist, to lay off 100 employees",
        "url": "https://urgent.news/2026/08/24/cellares-a-cell-therapy-manufacturing-specialist-to-lay-off-100",
        "published": "2026-08-24T15:19:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}